E Marion Schneider
Overview
Explore the profile of E Marion Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
3984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheiber C, Klein H, Schneider J, Schulz T, Bechter K, Tumani H, et al.
Cells
. 2024 Jul;
13(14.
PMID: 39056790
Virus-associated chronic inflammation may contribute to autoimmunity in a number of diseases. In the brain, autoimmune encephalitis appears related to fluctuating reactivation states of neurotropic viruses. In addition, viral miRNAs...
2.
Guggemos J, Fuller S, Skarratt K, Mayer B, Schneider E
Front Immunol
. 2024 Jul;
15:1352789.
PMID: 38966639
Introduction: Extracellular ATP (eATP) released from damaged cells activates the P2X7 receptor (P2X7R) ion channel on the surface of surrounding cells, resulting in calcium influx, potassium efflux and inflammasome activation....
3.
Kasper R, Rodriguez-Alfonso A, Standker L, Wiese S, Schneider E
Front Immunol
. 2024 May;
15:1359097.
PMID: 38698864
Introduction: In septic patients the damage of the endothelial barrier is decisive leading to circulatory septic shock with disseminated vascular coagulation, edema and multiorgan failure. Hemadsorption therapy leads to rapid...
4.
Li C, Schneider J, Schneider E
Cells
. 2024 Mar;
13(6.
PMID: 38534379
Disulfiram (DSF), an anti-alcoholism medicine, exerts treatment effects in patients suffering from persistent Borreliosis and also exhibits anti-cancer effects through its copper chelating derivatives and induction of oxidative stress in...
5.
Bolke E, van Griensven M, Schneider E, Fischer J, Feldt T, Keitel V, et al.
Front Immunol
. 2023 Jul;
14:1233291.
PMID: 37497232
No abstract available.
6.
Ning D, Garg K, Mayer B, Schick B, Bracht H, Barth E, et al.
Front Med (Lausanne)
. 2023 Jan;
9:1026298.
PMID: 36687421
Background: Sepsis causes a high rate of mortality and long-term morbidity, associated with an imbalance of innate immunity against infections and inflammation. Obesity and diabetes increase the risk for disease...
7.
Fischer J, Balz V, Jazmati D, Bolke E, Freise N, Keitel V, et al.
Eur J Med Res
. 2022 Nov;
27(1):255.
PMID: 36411478
Background: The presentation of peptides and the subsequent immune response depend on the MHC characteristics and influence the specificity of the immune response. Several studies have found an association between...
8.
Scheiber C, Schulz T, Schneider J, Bechter K, Schneider E
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337097
Affective (AF) and Schizophrenic (SZ) Spectrum disorders manifest with risk factors, involving inflammatory processes linked to infections and autoimmunity. This study searched for novel biomarkers in cerebrospinal fluid (CSF) and...
9.
Watanabe E, Takasu O, Teratake Y, Sakamoto T, Ikeda T, Kotani J, et al.
Front Med (Lausanne)
. 2022 Jan;
8:762198.
PMID: 35083232
Disseminated intravascular coagulation plays a key role in the pathophysiology of sepsis. Thrombomodulin is essential in the protein C system of coagulation cascade, and functional polymorphisms influence the human thrombomodulin...
10.
Fischer J, Schmidt A, Bolke E, Uhrberg M, Keitel V, Feldt T, et al.
Eur J Med Res
. 2021 Sep;
26(1):107.
PMID: 34530915
Background: COVID-19, the pandemic disease caused by infection with SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study...